AGN 2.91% 83.5¢ argenica therapeutics limited

Ann: No Serious Safety Issues Observed in First Cohort, page-8

  1. 775 Posts.
    lightbulb Created with Sketch. 74
    great explanation!

    Although you're correct, I feel ARG-007 will be the one.

    The credibility and capability of those recently employed gives a strong indication of their conviction in the drug itself.

    Quite true that many drugs have failed to replicate results on humans without negative Sid effects however ARG-007 was I believe the only one ever to demonstrate not a single side effect on an animal.

    correct me if I'm wrong but I'm unable to find another drug

    cheers
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
83.5¢
Change
-0.025(2.91%)
Mkt cap ! $103.2M
Open High Low Value Volume
87.0¢ 87.0¢ 82.0¢ $107.3K 128.2K

Buyers (Bids)

No. Vol. Price($)
2 6891 83.5¢
 

Sellers (Offers)

Price($) Vol. No.
86.0¢ 7770 1
View Market Depth
Last trade - 15.59pm 19/07/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.